This is because the PKM2 isoform is enriched in MYCN-amplified neuroblastoma cells due to the ability of the MYC transcription factors to transactivate the splicing factors PTBP1 and HNRNPA [42,43]. This evidence concerns the gene MYCN and neuroblastoma.